China Universal Asset Management »

Phathom Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $238k 13k 18.08
2024-06-30 $71k 6.9k 10.30
2024-03-31 $117k 11k 10.62
2023-12-31 $61k 6.6k 9.13
2023-09-30 $15k 1.5k 10.37
2023-06-30 $10k 717 14.32
2023-03-31 $4.0k 564 7.14
2022-12-31 $4.7k 423 11.22
2022-09-30 $4.0k 367 10.90

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Jennison Associates
Invesco
Carlyle
BlackRock
BlackRock
Ensign Peak Advisors
Woodline Partners
Vanguard Group
NEA Management Company
Avidity Partners Management
OrbiMed Advisors
Federated Investors
Decheng Capital

View all funds holding Phathom Pharmaceuticals